ImportantUpdates

Concord Biotech successfully completed an ANVISA inspection at its Limbasi API facility.

Concord Biotech Limited logo
Concord Biotech LimitedCONCORDBIO · Filed with the exchange

This strengthens its global manufacturing footprint, advancing international expansion and enhancing access to major pharmaceutical markets like Brazil, broadening the reach of its high-quality APIs.

Read the original filing(PDF)

No comments yet. Be the first.

More from Concord Biotech Limited

All announcements